Kinase AI

Software based on deep learning that would correlate between the set of mutations found in the kinase with the type of drug that needs to be used. The output drug would be based on two types: 1) newly generated drug structure or 2) A repurposed drug. The input would contain information from the transcriptomic data, already discovered drugs their structures and genomic signatures to name a few.

Skip to content